2853
Eosin B Solution
0.1% aqueous solution
Přihlásit pro zobrazení organizačních a smluvních cen.
Vybrat velikost
Změnit zobrazení
O této položce
Technický servis
Potřebujete pomoc? Náš tým zkušených odborníků je vám k dispozici.
Dovolte nám, abychom vám pomohliQuality Segment
form
solution
IVD
for in vitro diagnostic use
concentration
0.1%
application(s)
hematology
histology
storage temp.
room temp
SMILES string
[Na+].[Na+].[O-]C(=O)c1ccccc1C2=C3C=C(C(=O)C(Br)=C3Oc4c(Br)c([O-])c(cc24)[N+]([O-])=O)[N+]([O-])=O
InChI
1S/C20H8Br2N2O9.2Na/c21-14-16(25)11(23(29)30)5-9-13(7-3-1-2-4-8(7)20(27)28)10-6-12(24(31)32)17(26)15(22)19(10)33-18(9)14;;/h1-6,25H,(H,27,28);;/q;2*+1/p-2
InChI key
GYYTYUGGVBYJHE-UHFFFAOYSA-L
Application
Used as a counterstain in Sigma Procedure 285 for Fetal Hemoglobin.
Other Notes
Eosin B, 0.1%, aqueous solution. Sodium azide, 0.1% added as preservative
Skladovací třída
12 - Non Combustible Liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter
Vyberte jednu z posledních verzí:
Již tento produkt vlastníte?
Dokumenty související s produkty, které jste v minulosti zakoupili, byly za účelem usnadnění shromážděny ve vaší Knihovně dokumentů.
Související obsah
Nilay S Sethi et al.
Nature genetics, 52(2), 219-230 (2020-02-07)
Somatic alterations in cancer genes are being detected in normal and premalignant tissue, thus placing greater emphasis on gene-environment interactions that enable disease phenotypes. By combining early genetic alterations with disease-relevant exposures, we developed an integrative mouse model to study
Lucía Margarita Valenzuela-Salas et al.
Pharmaceutics, 13(1) (2021-01-13)
Nanomaterials quickly evolve to produce safe and effective biomedical alternatives, mainly silver nanoparticles (AgNPs). The AgNPs' antibacterial, antiviral, and antitumor properties convert them into a recurrent scaffold to produce new treatment options. This work reported the full characterization of a
Rocky Strollo et al.
Diabetologia, 58(12), 2851-2860 (2015-09-10)
Insulin is the most specific beta cell antigen and a potential primary autoantigen in type 1 diabetes. Insulin autoantibodies (IAAs) are the earliest marker of beta cell autoimmunity; however, only slightly more than 50% of children and even fewer adults
Globální číslo obchodní položky
| Skladová položka | GTIN |
|---|---|
| RDD013-500G | 04061836828431 |
| RDD013-100G | 04061836828417 |
| 1372609025 | 04065267204482 |
| 1372609010 | 04065267204475 |
| 1372601000 | 04065267204468 |
| 1372769025 | 04065267205113 |
| 1032520250 | 04022536040844 |
| 391335-1KG | 04055977190090 |
| 391335-100GM | 04055977190106 |
| 14879-100G-F | 04061838738059 |
| B4429-1KG | 04061835542857 |
| B4429-100G | 04061833429655 |
| B7535-100G | 04061833441893 |
| B9754-500G | 04061833443965 |
| B7535-25G | 04061833441909 |
| B7535-500G | 04061833441916 |
| B9754-1KG | 04061833443941 |
| 1372600003 | 04065267204444 |
| 1372761000 | 04065267205090 |
| 1372600100 | 04065267204451 |
| 1372760100 | 04065267205083 |
| 1372760003 | 04065267205076 |